COVID‐19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma …
PW Askenase - Journal of Extracellular Vesicles, 2020 - Wiley Online Library
Exosome extracellular vesicles as biologic therapy for COVID‐19 are discussed for two
areas. The first involves the growing use of mesenchymal stromal cells (MSCs) for the …
areas. The first involves the growing use of mesenchymal stromal cells (MSCs) for the …
Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study
M Dauletova, H Hafsan, N Mahhengam, AO Zekiy… - Clinical …, 2021 - Elsevier
In the past year, an emerging disease called Coronavirus disease 2019 (COVID-19), caused
by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been discovered in …
by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been discovered in …
International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells …
STATEMENT: The International Society for Cellular and Gene Therapies (ISCT) and the
International Society for Extracellular Vesicles (ISEV) recognize the potential of extracellular …
International Society for Extracellular Vesicles (ISEV) recognize the potential of extracellular …
[HTML][HTML] Diverse effects of exosomes on COVID-19: a perspective of progress from transmission to therapeutic developments
S Gurunathan, MH Kang, JH Kim - Frontiers in immunology, 2021 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new strain of
coronavirus and the causative agent of the current global pandemic of coronavirus disease …
coronavirus and the causative agent of the current global pandemic of coronavirus disease …
Mesenchymal stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises
L Rezakhani, AF Kelishadrokhi… - Chemistry and physics …, 2021 - Elsevier
There are no commercially available effective antiviral medications or vaccines to deal with
novel coronavirus disease (COVID-19). Hence there is a substantial unmet medical need for …
novel coronavirus disease (COVID-19). Hence there is a substantial unmet medical need for …
Exosomes in COVID‐19 infection: Focus on role in diagnosis, pathogenesis, immunity, and clinical trials
A Aljuhani, O Albalawi, R Albalawi… - Cell Biology …, 2023 - Wiley Online Library
Since the end of 2019, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
spread as a new strain of coronavirus disease (COVID‐19) and progressed as a global …
spread as a new strain of coronavirus disease (COVID‐19) and progressed as a global …
[HTML][HTML] Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatmen
K Jayaramayya, I Mahalaxmi, MD Subramaniam… - BMB …, 2020 - ncbi.nlm.nih.gov
The world has witnessed unimaginable damage from the coronavirus disease-19 (COVID-
19) pandemic. Because the pandemic is growing rapidly, it is important to consider diverse …
19) pandemic. Because the pandemic is growing rapidly, it is important to consider diverse …
Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia
Background The outbreak of a new virus known as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has now become the main health concern all over the world …
coronavirus 2 (SARS-CoV-2) has now become the main health concern all over the world …
The potential use of mesenchymal stem cells and their derived exosomes as immunomodulatory agents for COVID‐19 patients
A novel severe acute respiratory syndrome coronavirus (SARS‐CoV‐2) causing lethal acute
respiratory disease emerged in December 2019. The World Health Organization named this …
respiratory disease emerged in December 2019. The World Health Organization named this …
Mesenchymal stem cells and their derived exosomes to combat Covid–19
M Yousefi Dehbidi, N Goodarzi… - Reviews in Medical …, 2022 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is causing an ongoing
pandemic of coronavirus disease 2019 (Covid‐19). Effective therapies are required for the …
pandemic of coronavirus disease 2019 (Covid‐19). Effective therapies are required for the …